Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-16-018724
Filing Date
2016-12-16
Accepted
2016-12-15 18:01:31
Documents
14
Period of Report
2016-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp71131_6k.htm 6-K 18104
2 EXHIBIT 99.1 dp71131_ex9901.htm EX-99.1 15238
3 EXHIBIT 99.2 dp71131_ex9902.htm EX-99.2 1487
4 GRAPHIC image_011.jpg GRAPHIC 63215
5 GRAPHIC image_012.jpg GRAPHIC 56169
6 GRAPHIC image_013.jpg GRAPHIC 78575
7 GRAPHIC image_014.jpg GRAPHIC 84772
8 GRAPHIC image_015.jpg GRAPHIC 66540
9 GRAPHIC image_016.jpg GRAPHIC 48168
10 GRAPHIC image_017.jpg GRAPHIC 70863
11 GRAPHIC image_018.jpg GRAPHIC 70553
12 GRAPHIC image_019.jpg GRAPHIC 82391
13 GRAPHIC image_020.jpg GRAPHIC 75447
14 GRAPHIC image_022.gif GRAPHIC 105295
  Complete submission text file 0000950103-16-018724.txt   1141423
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 162054680
SIC: 2834 Pharmaceutical Preparations